News about "Emcure Pharmaceuticals "

Emcure Takes Full Ownership of Gennova, Strengthens Focus on Biologics and Biosimilars

Emcure Pharmaceuticals has acquired the remaining minority stake in Gennova Biopharmaceuticals, making it a wholly owned subsidiary while appointing Samit Mehta to lead the company’s next phase of growth in biologics and biosimilars.

Emcure Pharmaceuticals | 14/07/2026 | By News Bureau

Emcure's Marcan Pharma to Acquire Remaining Stake in Mantra Pharma

Emcure Pharmaceuticals' subsidiary Marcan Pharmaceuticals has signed agreements to acquire the remaining Class E Special Shares of Canada's Mantra Pharma, making the company a wholly owned subsidiary.

Emcure Pharmaceuticals | 06/07/2026 | By News Bureau

Emcure Slashes Price of Semaglutide-Based Weight Loss Drug Poviztra in India

Emcure reduces the price of its semaglutide-based drug Poviztra, aiming to make effective weight management treatment more accessible to patients across India.

Emcure Pharmaceuticals | 04/04/2026 | By News Bureau |  157

Emcure Launches Poviztra to Broaden Access to Weight Management Therapy

Emcure has launched Poviztra, a once-weekly weight management therapy available in a pen device across five dosage strengths, with prices starting at INR 8,790 per month, aimed at improving access through convenient and precise dosing.

Emcure Pharmaceuticals | 22/12/2025 | By News Bureau |  333

Novo Nordisk India partners with Emcure Pharma to commercialise Poviztra in India

Under this agreement, Emcure becomes the first Indian company to hold exclusive rights for the distribution and commercialisation of the drug, expanding access to Novo Nordisk’s innovative semaglutide therapy for people living with overweight and obesity in the country.

Emcure Pharmaceuticals | 10/11/2025 | By Dineshwori |  769

Emcure Pharma Delivers Robust Performance Across All Businesses in Q1FY26: Satish Mehta

Emcure Pharmaceuticals reported strong financial results for the first quarter of FY26, demonstrating impressive growth in both domestic and international businesses.

Emcure Pharmaceuticals | 07/08/2025 | By Dineshwori |  526

Sanofi India, Emcure Sign Exclusive Distribution Partnership for Anti-Diabetic Drugs

Sanofi India Ltd. has entered into an exclusive distribution and promotion agreement with Emcure Pharmaceuticals for its oral anti-diabetic brands, including Amaryl and Cetapin, aiming to expand patient access and strengthen diabetes care across India.

Emcure Pharmaceuticals | 17/07/2025 | By Mrinmoy Dey |  394

Emcure Pharma Taps Industry Veteran R.S. Vasan to Lead India Business

Emcure Pharmaceuticals Ltd. has appointed R.S. Vasan as President – India Business and Senior Management Personnel (SMP).

Emcure Pharmaceuticals | 16/07/2025 | By Dineshwori |  506

Emcure Pharmaceuticals Launches its R&D Centre in Ahmedabad

The Emcure Research Centre (ERC) is strategically designed to enable breakthroughs in complex drug delivery systems, such as sustained-release formulations, liposomal injections and advanced dermal therapies.

Emcure Pharmaceuticals | 23/01/2025 | By Aishwarya |  995

Emcure Launches New Entity Emcutix Biopharmaceuticals for Dermatology Sector

As a part of this strategic initiative, Emcure's existing dermatology business will also operate under Emcutix.

Emcure Pharmaceuticals | 29/10/2024 | By Aishwarya |  1101